The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-Alcoholic Steatohepatitis (NASH)

被引：0
|
作者：
Drescher, Hannah [1 ]
Weiskirchen, Ralf [2 ]
Tolba, Rene [3 ,4 ]
Trautwein, Christian [1 ]
Kroy, Daniela [1 ]
机构：
[1] Rhein Westfal TH Aachen, Univ Hosp, Dept Internal Med 3, Aachen, Germany
[2] Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Pathobiochem Expt Gene Therapy & Clin Ch, Cleveland, OH USA
[3] Rhein Westfal TH Aachen, Univ Hosp, Inst Lab Anim Sci & Expt Surg, Cleveland, OH USA
[4] Rhein Westfal TH Aachen, Univ Hosp, Cent Lab Lab Anim Sci, Cleveland, OH USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1816
引用
收藏
页码：1031A / 1031A
页数：1
相关论文
共 50 条
  • [31] AGREEMENT BETWEEN DIFFERENT PATHOLOGIC CRITERIA FOR NON-ALCOHOLIC STEATOHEPATITIS (NASH)
    Rafiq, N.
    Stepanova, M.
    Makhlouf, H.
    Agrawal, R.
    Younoszai, Z.
    Hallaji, S.
    Goodman, Z.
    Younossi, Z.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S351 - S351
  • [32] Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats
    Zheng-Jie Xu
    Jian-Gao Fan
    Xiao-Dong Ding
    Liang Qiao
    Guo-Liang Wang
    Digestive Diseases and Sciences, 2010, 55 : 931 - 940
  • [33] Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats
    Xu, Zheng-Jie
    Fan, Jian-Gao
    Ding, Xiao-Dong
    Qiao, Liang
    Wang, Guo-Liang
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (04) : 931 - 940
  • [34] Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model
    Elbadawy, Mohamed
    Yamanaka, Megumi
    Goto, Yuta
    Hayashi, Kimika
    Tsunedomi, Ryouichi
    Hazama, Shoichi
    Nagano, Hiroaki
    Yoshida, Toshinori
    Shibutani, Makoto
    Ichikawa, Ryo
    Nakahara, Junta
    Omatsu, Tsutomu
    Mizutani, Tetsuya
    Katayama, Yukie
    Shinohara, Yuta
    Abugomaa, Amira
    Kaneda, Masahiro
    Yamawaki, Hideyuki
    Usui, Tatsuya
    Sasaki, Kazuaki
    BIOMATERIALS, 2020, 237
  • [35] TRAIL deficiency protects against fibrosis in murine non-alcoholic steatohepatitis (NASH)
    Hirsova, Petra
    Weng, Peggy
    Ibrahim, Samar H.
    Bronk, Steven
    Gores, Gregory J.
    HEPATOLOGY, 2016, 64 : 753A - 754A
  • [36] Hepatic FXR's Protective Role Against Non-Alcoholic Steatohepatitis (NASH) Development in a High-Fat Diet Induced Non-Alcoholic Fatty Liver Disease (NAFLD) Mouse Model.
    Armstrong, Laura Elizabeth
    Kong, Bo
    Shen, Jianliang
    Rui, Liangyou
    Schumacher, Justin
    Chow, Monica D.
    Lee, Yi-Horng
    Guo, Grace L.
    HEPATOLOGY, 2018, 68 : 752A - 753A
  • [37] Therapeutic effects of restricted diet and exercise in patients with non-alcoholic steatohepatitis (NASH).
    Sasaki, N
    Ueno, T
    Morita, Y
    Yoshioka, S
    Nagata, E
    Tanikawa, K
    Sata, M
    HEPATOLOGY, 2002, 36 (04) : 729A - 729A
  • [38] Towards the development of a scoring system for diagnosing Non-alcoholic Steatohepatitis (NASH).
    Khan, AR
    Riley, TR
    HEPATOLOGY, 2001, 34 (04) : 695A - 695A
  • [39] Effect of Losartan on liver fibrosis development in a rat model of non-alcoholic steatohepatitis
    Ibanez, P
    Pizarro, M
    Solis, N
    Aguayo, G
    Duarte, I
    Accatino, L
    Arrese, MA
    GASTROENTEROLOGY, 2004, 126 (04) : A688 - A689
  • [40] DEVELOPMENT AND VALIDATION OF NASH DIAGNOSTIC INDEX AS A NON-INVASIVE MODEL FOR DIAGNOSING NON-ALCOHOLIC STEATOHEPATITIS (NASH)
    Younossi, Z. M.
    Otgonsuren, M.
    Hunt, S.
    Afendy, A.
    Goodman, Z.
    Fang, Y.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S554 - S554
12345